Last Updated on December 31, 2023 by The Health Master
The pharma major, Cipla, has announced that the company has received six observations from the US Food and Drug Administration (USFDA) following the inspection conducted in August 2022 at its Goa plant.
The company said the Goa plant recently underwent a United States Food and Drug Administration (USFDA) inspection from August 16 to 26, 2022.
Earlier, the USFDA inspected the company’s Goa manufacturing facility in September 2019. A warning letter for the same was received by the company in February 2020.
The company further informed that on the conclusion of the inspection, the company has now received 6 observations, with some referencing to the observations made during the September 2019 inspection. There are no data integrity observations.
“The company will work closely with the USFDA and is committed to addressing these within the stipulated time, the company said in a filing with BSE.
Cipla Limited is an Indian multinational pharmaceutical and biotechnology company, headquartered in Mumbai, India. The Company was founded by Khwaja Abdul Hamied in 1935 in Mumbai.
Cipla primarily develops medicines to treat respiratory and cardiovascular disease, arthritis, diabetes, weight control, depression, and other medical conditions.
UFDA issues Form 483 to Cipla’s facility in MP
USFDA issues Form 483 with 6 observations to Sun Pharma
USFDA issues Form 483 for 4 observations to Zydus
USFDA completes inspection at Stride Pharma with zero observation
USFDA issues Form 483 for 6 observations to Jubilant Pharmova
USFDA issues Form 483 for 3 observations to Aurobindo Pharma
Penalty provision for Blood Banks / Centres not updating stock in time
Govt invites eligible Medical Devices Firms Category B of PLI scheme
Drug Rules 1945 amended to allow parallel submission of manufacturing & marketing approvals
USFDA gives approval for this Contraceptive
This Air is an essential element for the Tablet Coating Process
USFDA gives nod for Formoterol Fumarate inhalation solution
NPPA fixes Retail Prices of 45 drug formulations
CDSCO panel wants justification on Protocol Amendments on Trail of Imlunestrant
USFDA gives nod for generic Carbamazepine tablets
Latest Notifications regarding Pharmaceuticals
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
